1.10
11.65%
-0.145
Dopo l'orario di chiusura:
1.15
0.05
+4.55%
Cue Biopharma Inc Azioni (CUE) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
5.71%
1.717
|
1.821 | 2.10 | 1.382 | 0.187 |
Operating Expenses
|
8.10%
14.38
|
15.65 | 13.52 | 14.90 | 13.57 |
Interest Income/Expense |
104.60%
0.033
|
-0.718 | 0.254 | 0.35 | 0.3304 |
Benefits Costs and Expenses |
7.81%
14.06
|
15.26 | - | - | 13.30 |
Costs And Expenses |
7.81%
14.06
|
15.26 | 13.52 | 14.90 | 13.30 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Depreciation and Amortization |
12.39%
0.099
|
0.113 | 0.13 | 0.136 | 0.177 |
Operating Income/Loss |
8.42%
-12.67
|
-13.83 | -11.42 | -13.52 | -13.38 |
Net Interest Income/Expense |
52.47%
-0.241
|
-0.507 | -0.286 | -0.232 | -0.37 |
Nonoperating Income/Loss
|
19.35%
0.321
|
0.398 | 0.414 | 0.332 | 0.271 |
Income/Loss From Continuing Operations Before Tax |
8.09%
-12.35
|
-13.43 | 2.10 | 1.382 | -13.11 |
Income/Loss From Continuing Operations After Tax |
8.09%
-12.35
|
-13.43 | -11.01 | -13.19 | -13.11 |
Net Income/Loss
|
8.09%
-12.35
|
-13.43 | -11.01 | -13.19 | -13.11 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
10,191%
49.47
|
0.4807 | 46.36 | 44.80 | 44.65 |
Diluted Average Shares |
10,191%
49.47
|
0.4807 | 46.36 | 44.80 | 44.65 |
Basic Earnings Per Share |
13.79%
-0.25
|
-0.29 | -0.24 | -0.29 | -0.29 |
Diluted Earnings Per Share |
13.79%
-0.25
|
-0.29 | -0.24 | -0.29 | -0.29 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):